Furthermore, an HERV-K-specific T cell response was observed in PBMCs from BC patients after in vitro stimulation with HERV-K env antigen, and a cytolytic activity against HERV-K targets could be detected. The gene discussed is ERVW-1; the disease is breast cancer.